Region | # |
---|---|
AS - Asia, other | 160 |
NA - North America | 75 |
AF - Africa | 1 |
Unknown | 6 |
Total | 242 |
Country | # |
---|---|
CN - China | 143 |
US - United States of America | 75 |
TW - Taiwan | 15 |
SG - Singapore | 2 |
NG - Nigeria | 1 |
Unknown | 6 |
Total | 242 |
City | # |
---|---|
Inglewood | 45 |
Beijing | 38 |
Zhengzhou | 21 |
Xinxiang | 17 |
Taipei | 15 |
Shenzhen | 3 |
Zhumadian | 3 |
Benin City | 1 |
Chongqing | 1 |
Fuzhou | 1 |
other | 97 |
Total | 242 |
Most viewed projects | # |
---|---|
ID: 114540 - Investigation of Akt as a Therapeutic Target for Asxl1-Mutated Myeloid Malignancies | 39 |
Total | 39 |
???view.stats-crisStatistics.data.top.crispj.category.title??? | ???view.stats-crisStatistics.data.top.crispj.category.value??? |
---|---|
ID: selectedproject - | 0 |
ID: investigatored - | 0 |
ID: coinvestigatored - | 0 |
Total | 0 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
2021 | 14 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 0 | 20 |
2022 | 0 | 0 | 1 | 1 | 0 | 4 | 1 | 8 | 0 | 4 | 16 | 12 | 47 |
2023 | 0 | 7 | 10 | 12 | 5 | 0 | 1 | 6 | 1 | 1 | 7 | 33 | 83 |
2024 | 14 | 17 | 19 | 41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 91 |
Ever | 242 |